Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Testicular Neoplasms × avelumab × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 11 Urinary Bladder Neoplasms 9 Neoplasms 8 Ovarian Neoplasms 6 Neoplasm Metastasis 6 Carcinoma, Renal Cell 5 Pancreatic Neoplasms 4 Carcinoma, Transitional Cell 4 Carcinoma, Merkel Cell 4 Breast Neoplasms 4 Lymphoma 3 Fallopian Tube Neoplasms 3 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Prostatic Neoplasms 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Kidney Neoplasms 2 Kidney Diseases 2 Colorectal Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Urothelial Cancer 1 Urologic Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Turcot syndrome 1 Stomach Neoplasms 1 Sezary Syndrome 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1

Interventions

Ifosfamide 8 Carboplatin 7 Paclitaxel 5 Filgrastim 5 Etoposide 5 Dexamethasone 3 Stem Cell Transplantation 2 Peripheral Blood Stem Cell Transplantation 2 Ondansetron 2 Mesna 2 Granulocyte Colony-Stimulating Factor 2 Calcium Dobesilate 2 Aprepitant 2 tremelimumab 1 thymoglobulin 1 poly ICLC 1 pembrolizumab 1 palifosfamide lysine 1 palbociclib 1 isophosphamide mustard 1 fosaprepitant 1 etoposide phosphate 1 erythromycin propionate-N-acetylcysteinate 1 durvalumab 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 dehydroftorafur 1 cytokine inducible SH2-containing protein 1 alvocidib 1 Thiotepa 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡